학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

Document Type

Article

Author

von Minckwitz, Gunter; Puglisi, Fabio; Cortes, Javier; Vrdoljak, Eduard; Marschner, Norbert; Zielinski, Christoph; Villanueva, Cristian; Romieu, Gilles; Lang, István; Ciruelos, Eva; De Laurentiis, Michele; Veyret, Corinne; de Ducla, Sabine; Freudensprung, Ulrich; Srock, Stefanie; Gligorov, Joseph

Source

In Lancet Oncology October 2014 15(11):1269-1278

Subject

Primary Research
Articles

Language

ISSN

1470-2045

Online Access

Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일